Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 05, 2020

SELL
$11.73 - $16.25 $541,316 - $749,905
-46,148 Closed
0 $0
Q2 2020

Jul 22, 2020

SELL
$13.68 - $20.46 $979,351 - $1.46 Million
-71,590 Reduced 60.8%
46,148 $741,000
Q1 2020

May 06, 2020

BUY
$14.83 - $26.72 $803,281 - $1.45 Million
54,166 Added 85.2%
117,738 $1.83 Million
Q4 2019

Feb 03, 2020

BUY
$9.77 - $24.6 $621,098 - $1.56 Million
63,572 New
63,572 $1.56 Million
Q3 2018

Oct 25, 2018

SELL
$9.5 - $13.75 $411,274 - $595,265
-43,292 Closed
0 $0
Q2 2018

Aug 02, 2018

BUY
$12.85 - $18.45 $556,302 - $798,737
43,292 New
43,292 $587,000

About Epizyme, Inc.


  • Ticker EPZM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 168,364,992
  • Market Cap $247M
More about EPZM
Track This Portfolio

Track First Trust Advisors LP Portfolio

Follow First Trust Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.